Ohad is a Partner at Pontifax, where he is in charge of scouting and project evaluation.

In his role at Pontifax, Ohad is also involved in the formation and development strategy of the fund’s early-stage portfolio companies.

He serves as a director in Metabomed, Pi Therapeutics, Keros Therapeutics, Eyevensys and TargEDys. Ohad obtained his M.S. in Biology from Tel-Aviv University


Our board of directors is made up of seasoned industry investors and executives who provide their leadership and experience as we progress our promising pipeline into the clinic.